Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Earl

Showing results (141-150 of 265) with videos related to

Pageof 27
Sort By:
British Journal of Cancer|July 31, 2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluationA M Wardley, L Hiller, H C Howard, et al.
British Journal of Cancer|January 10, 2013
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trialE Provenzano, A-L Vallier, R Champ, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancerC J Poole, T Perren, A Burton, et al.
Mbio|October 2, 2025
The carbapenem inoculum effect provides insights into the molecular mechanisms underlying carbapenem resistance in the EnterobacteralesAlexis Jaramillo Cartagena, Kyra L Taylor, Leslie C Lopez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
CYP2D6 gene variants and their association with breast cancer susceptibilityJean E Abraham, Mel J Maranian, Kristy E Driver, et al.
British Journal of Cancer|September 1, 1991
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trialH M Earl, R M Rudd, S G Spiro, et al.
The Journal of Infectious Diseases|November 23, 2023
Utility of Mycobacterium tuberculosis Genome Sequencing Snapshots to Assess Transmission Dynamics Over TimeCourtney M Yuen, Chuan-Chin Huang, Ana Karina Millones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancerR L Souhami, H T Hajichristou, D W Miles, et al.
Science (New York, N.Y.)|February 19, 2021
Clinically relevant mutations in core metabolic genes confer antibiotic resistanceAllison J Lopatkin, Sarah C Bening, Abigail L Manson, et al.
International Journal of Systematic and Evolutionary Microbiology|May 15, 2014
Oribacterium parvum sp. nov. and Oribacterium asaccharolyticum sp. nov., obligately anaerobic bacteria from the human oral cavity, and emended description of the genus OribacteriumMaria V Sizova, Paul A Muller, David Stancyk, et al.
Pageof 27

Showing results (141-150 of 265) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|July 31, 2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluationA M Wardley, L Hiller, H C Howard, et al.
British Journal of Cancer|January 10, 2013
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trialE Provenzano, A-L Vallier, R Champ, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancerC J Poole, T Perren, A Burton, et al.
Mbio|October 2, 2025
The carbapenem inoculum effect provides insights into the molecular mechanisms underlying carbapenem resistance in the EnterobacteralesAlexis Jaramillo Cartagena, Kyra L Taylor, Leslie C Lopez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
CYP2D6 gene variants and their association with breast cancer susceptibilityJean E Abraham, Mel J Maranian, Kristy E Driver, et al.
British Journal of Cancer|September 1, 1991
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trialH M Earl, R M Rudd, S G Spiro, et al.
The Journal of Infectious Diseases|November 23, 2023
Utility of Mycobacterium tuberculosis Genome Sequencing Snapshots to Assess Transmission Dynamics Over TimeCourtney M Yuen, Chuan-Chin Huang, Ana Karina Millones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancerR L Souhami, H T Hajichristou, D W Miles, et al.
Science (New York, N.Y.)|February 19, 2021
Clinically relevant mutations in core metabolic genes confer antibiotic resistanceAllison J Lopatkin, Sarah C Bening, Abigail L Manson, et al.
International Journal of Systematic and Evolutionary Microbiology|May 15, 2014
Oribacterium parvum sp. nov. and Oribacterium asaccharolyticum sp. nov., obligately anaerobic bacteria from the human oral cavity, and emended description of the genus OribacteriumMaria V Sizova, Paul A Muller, David Stancyk, et al.
Pageof 27